Exos TFP Holdings’s G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 GSQB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-59,400
Closed -$2.38K 461
2023
Q1
$2.38K Hold
59,400
﹤0.01% 412
2022
Q4
$2.38K Buy
+59,400
New +$3.9K ﹤0.01% 474

Other funds holding GSQB.WS

Exos TFP Holdings's GSQB.WS Position: Q2 2023 in Review

Exos TFP Holdings sold out of G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (GSQB.WS) in Q2 2023, closing a stake of 59,400 shares — an estimated $2.38K sold.

Exos TFP Holdings first reported a position in GSQB.WS in Q4 2022 and held it in 2 quarters. The position peaked at $2.38K in Q4 2022. 3 funds tracked by Wall St. Rank hold GSQB.WS as of Q2 2023.

  • Exos TFP Holdings reported no remaining G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 59,400 G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $2.38K.
  • Exos TFP Holdings first reported a position in G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2022 and held it in 2 quarters.
  • Exos TFP Holdings's G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $2.38K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.